Opendata, web and dolomites

LPPDS

A portable peritoneal dialysis system for home use that monitors for infection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LPPDS project word cloud

Explore the words cloud of the LPPDS project. It provides you a very rough idea of what is the project "LPPDS" about.

disease    adherence    human    complexity    decline    pd    chronic    treatment    lppds    travelling    sterile    rate    market    longer    share    hospitals    catheters    flow    waste    stage    errors    doctor    exchange    times    health    connectors    liberdi    pending    aging    lightweight    schedules    patent    diabetes    ease    obesity    either    sufficiently    minutes    patient    revolutionises    doctors    caused    automation    transplant    external    centres    consists    53    seeing    renal    session    globally    function    hypertension    population    fifth    end    public    home    eskd    correct    plans    adding    epidemics    disposable    filtering    time    requiring    saving    economic    holds    issue    esrd    occurs    difficult    device    haemodialysis    designed    blood    inhibit    prevalence    offerings    compliance    recognised    portable    core    pump    travel    week    protocol    peritoneal    speeds    carry    west    fluid    kidney    hd    truly    latter    patients    takes    calculate    ckd    last    ux    monitoring    smart    poorer    efficacy    socio    kidneys    hours    decreasing    day    dialysis    peristaltic    choosing    reduce   

Project "LPPDS" data sheet

The following table provides information about the project.

Coordinator
LIBERDI LTD 

Organization address
address: 17 T'CHELET STREET
city: MISGAV
postcode: 2017400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.liberdi.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIBERDI LTD IL (MISGAV) coordinator 50˙000.00

Map

 Project objective

End Stage Kidney Disease (ESKD) or End Stage Renal Disease (ESRD), the fifth and last stage of Chronic Kidney Disease (CKD), is recognised as a major public health problem. It occurs where kidneys are no longer capable of sufficiently filtering waste products from the blood. With kidney function at less than 10 %, a kidney transplant or an external means of filtering is needed. The latter consists of either Haemodialysis (HD) or Peritoneal Dialysis (PD). Globally, we are seeing an increasing prevalence in ESRD. This is caused by an aging population in the west, socio-economic factors, increasing hypertension, and growing diabetes and obesity epidemics.

The technical complexity of market offerings can inhibit many patients from choosing PD. HD takes an average of 4 hours per treatment session and occurs 3 times a week while PD occurs 4 times a day with each exchange requiring 40 minutes on average. Most dialysis occurs in specific dialysis centres and hospitals, adding further time for travel. Non-compliance with treatment schedules are a particular issue with PD. This makes it difficult for doctors to calculate correct treatment plans as patients may not share this information with their doctor. Non-compliance can be as high as 53%, decreasing efficacy of the treatment leading to poorer health overall and speeds up rate of decline.

liberDi revolutionises traditional Peritoneal Dialysis with LPPDS, a smart, real-time, patient-monitoring, truly portable device. It’s lightweight, easy to set up and allows patients carry out their dialysis at home, at work or while travelling. LPPDS has UX at the very core of its design to ensure ease of use: patent pending smart automation, catheters and sterile connectors. The system consists of a patent-pending disposable that holds a smart peristaltic pump designed to improve adherence to protocol, and reduce human errors, while saving time via fluid flow rate and management.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LPPDS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LPPDS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COUNTMITMENT (2019)

NATURAL CAPITAL ACCOUNTANCY TO IMPROVE REPORTING AND ENVIRONMENTAL PERFORMANCE

Read More  

PICSOHF (2020)

PICSOHF, A minimally invasive cardiac intervention medical device to regenerate a damaged heart and extend the life of patients with Heart Failure

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More